Cysteamine
SIGMA/30070 - ≥98.0% (RT)
Synonym: β-Mercaptoethylamine; 2-Aminoethanethiol; 2-Mercaptoethylamine; Decarboxycysteine; MEA; Thioethanolamine
CAS Number: 60-23-1
Empirical Formula (Hill Notation): C2H7NS
Molecular Weight: 77.15
EC Number: 200-463-0
MDL Number: MFCD00008196
Linear Formula: NH2CH2CH2SH
Product Type: Chemical
| assay | ≥98.0% (RT) |
| InChI | 1S/C2H7NS/c3-1-2-4/h4H,1- |
| InChI key | UFULAYFCSOUIOV-UHFFFAOYSA |
| Quality Level | 200  |
| SMILES string | NCCS |
| storage temp. | 2-8°C |
| Application: | Cysteamine is suitable for use: • in the preparation of cysteamine modified gold nanoparticles (AuNP) • in the fabrication of SU-8 microrods, where in, the amine group of cysteamine reacts with the unreacted epoxide rings present on the surface of the particles, thereby opening it and forming a covalent bond • to enhance in vitro development of porcine oocytes matured and fertilized in vitro • in a study to demonstrate the depletion effect of cysteamine on cystinotic leucocyte granular fractions of cystine by disulphide interchange • as a radioprotector • to administer subcutaneously in rats to study its blocking effect on somatostatin secretion without modifying the pancreatic insulin or glucagon content • as a scavenger in electrophoretic gels (acetic acid/urea gels) |
| Biochem/physiol Actions: | Cysteamine (β-mercaptoethylamine) depletes cystine from patient′s cells and there by regulates renal glomerular function and increases growth in them. Therefore, cysteamine is considered to be a potential therapeutic for nephropathic cystinosis. |
| Symbol |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 - H335 |
| Precautionary statements | P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | UN 3335 |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98.0% (RT) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352116 |